Results 211 to 220 of about 26,048 (254)
Some of the next articles are maybe not open access.
Bisphosphonates for Osteoporosis
New England Journal of Medicine, 2010A 67-year-old woman is referred by her primary care physician for treatment of osteoporosis and progressive bone loss. Oral bisphosphonate therapy is recommended. Bisphosphonates suppress bone resorption by interfering with osteoclast activity. Several of these agents have been shown to prevent fractures and increase bone mineral density in patients ...
openaire +2 more sources
Pharmacology of bisphosphonates
Bone, 2011Four decades of preclinical and clinical research of the pharmacology of bisphosphonates have generated data and concepts that have considerably improved their clinical use. However, despite this progress several pharmacological aspects relevant to bisphosphonate action on bone are still incompletely understood.
Cremers, S., Papapoulos, S.
openaire +3 more sources
Bisphosphonates and atherosclerosis
General Pharmacology: The Vascular System, 2000Bisphosphonates are used for the treatment of bone resorption, hypercalcemia, osteoporosis and Paget's disease. Etidronate, pamidronate and clodronate also inhibit the development of experimental atherosclerosis without altering serum lipid profile. Bisphosphonates inhibit the arterial calcification, lipid accumulation and fibrosis.
openaire +2 more sources
[Corticotherapy and bisphosphonates].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005Corticotherapy and ...
openaire +2 more sources
Rheumatic Disease Clinics of North America, 2012
Bisphosphonates are antiresorptive medications widely prescribed for treating osteoporosis. In placebo-controlled clinical trials they have been shown to significantly reduce the risk of osteoporotic fractures. However, reports of atypical femoral fractures and osteonecrosis of the jaw have emerged with long-term use, raising questions regarding their ...
Catalina, Orozco, Naim M, Maalouf
openaire +2 more sources
Bisphosphonates are antiresorptive medications widely prescribed for treating osteoporosis. In placebo-controlled clinical trials they have been shown to significantly reduce the risk of osteoporotic fractures. However, reports of atypical femoral fractures and osteonecrosis of the jaw have emerged with long-term use, raising questions regarding their ...
Catalina, Orozco, Naim M, Maalouf
openaire +2 more sources
Current Rheumatology Reports, 2004
Over the past 15 years, bisphosphonates have been demonstrated as effective therapy for the treatment of osteoporosis based on their ability to suppress bone turnover resulting in increased bone mineral content and increased bone strength. The mechanism of action at the cellular level has been identified, and the more potent nitrogen-containing ...
openaire +2 more sources
Over the past 15 years, bisphosphonates have been demonstrated as effective therapy for the treatment of osteoporosis based on their ability to suppress bone turnover resulting in increased bone mineral content and increased bone strength. The mechanism of action at the cellular level has been identified, and the more potent nitrogen-containing ...
openaire +2 more sources
Journal of Palliative Medicine, 2009
Bisphosphonates have become an important treatment for the palliation of metastatic bone disease. Their increasing use has lead to the recognition of toxicities that can lead to substantial morbidity for the patient with advanced cancer. This case presentation highlights toxicities associated with bisphosphonate use and provides some guidelines on the ...
openaire +2 more sources
Bisphosphonates have become an important treatment for the palliation of metastatic bone disease. Their increasing use has lead to the recognition of toxicities that can lead to substantial morbidity for the patient with advanced cancer. This case presentation highlights toxicities associated with bisphosphonate use and provides some guidelines on the ...
openaire +2 more sources
Bisphosphonate Treatment of Osteoporosis
Clinics in Geriatric Medicine, 2000Bisphosphonates represent the agents of choice for most patients with osteoporosis. They are the best studied of all agents for the prevention of bone loss and reduction in fractures. They increase BMD, primarily at the lumbar spine, but also at the proximal femur.
openaire +2 more sources
TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES
Rheumatic Disease Clinics of North America, 1994Several bisphosphonates are effective for preventing bone loss associated with estrogen deficiency, glucocorticoid treatment, and immobilization, and for at least partially reversing bone loss in patients with postmenopausal osteoporosis and steroid-induced osteoporosis.
openaire +4 more sources